Abstract

Objective This study evaluated the effects of di-(2-ethylhexyl) phthalate (DEHP) and obesity on male reproductive organ function in male mice and the potential mechanism of male secondary hypogonadism (SH) in such mice. Methods 140 mice were assigned to six groups for 12 weeks: normal, DEHP, DIO, DIO + DEHP low, DIO + DEHP middle, and DIO + DEHP high. The effects of DEHP and obesity upon the reproductive organs were determined by measuring sperm count and motility, relative testis and epididymis weight, hormone level, and pathological changes. Oxidative stress was evaluated by determining malondialdehyde, T-AOC, SOD, GSH, H2O2, CAT, and GSH-PX in testicular tissues. Nrf2 and Keap1 protein were measured by Western blotting. Results DEHP and obesity reduced sperm count and motility, relative testis and epididymis weight, and testosterone level but increased the levels of MDA, H2O2, leptin, and estradiol. Pathological injury was observed in the testicular Leydig cells. Moreover, the activity of CAT, SOD, and GSH-Px enzymes was inhibited. Nrf2 protein expression was reduced but that of Keap1 was increased. Conclusions DEHP and obesity jointly caused damage to male productive function. Oxidative stress in testicular tissue, and a high level of leptin, may provide some evidence to clarify the mechanisms of male SH with DEHP and obesity.

Highlights

  • Obesity is a multifactorial condition with syndromic and nonsyndromic variants

  • We found that the levels of GSH-PX in DIO + di-(2-ethylhexyl) phthalate (DEHP) middle and DIO + DEHP high mice were significantly lower compared to the DIO + DEHP low mice (P < 0 05; Table 3)

  • The weight of DEHP mice was higher than the control mice; there was no significant difference in weight between the DEHP and control group prior to exposure to DEHP

Read more

Summary

Introduction

Obesity is a multifactorial condition with syndromic and nonsyndromic variants. During 2011–2014, the prevalence of obesity in adults in the United States of America was over 36% [1]. A 2014 study of chronic disease and nutrition in the Chinese population revealed that the prevalence of obesity and excessive weight gain was 11.9% and 30.1% among adults [2]. Even in the absence of organic disease in the hypothalamopituitary axis, the prevalence of secondary (hypogonadotropic) hypogonadism (SH) in obese men has been demonstrated in several studies [4,5,6]. Male obesity has been associated with lower plasma testosterone levels [7, 8]. Since the development of the male reproductive organs and male secondary sexual characteristics is promoted by androgens, and since spermatogenesis is closely related to androgen secretion, it follows that reduced levels of testosterone may contribute to male SH in obesity [9]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call